TRIB Trinity Biotech: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Trinity Biotech plc (TRIB) generates revenue through the supply of diagnostic systems, where equipment sales guarantee recurring income from the sale of consumables. This EV/EBITDA chart reflects a current multiple of 0.00. The business relies on steady demand for the detection of critical pathologies, establishing the company as a defensive asset with revenue secured by multi-year agreements with medical centers.
Analytical breakdowns for trinitybiotech.com (TRIB)
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Trinity Biotech plc|TRIB - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Trinity Biotech|TRIB - Aggregate Debt Obligations|Debts to Book Capitalization Trinity Biotech plc|TRIB - Long-Term Debt Volume|Company Short-Term Debt Trinity Biotech|Quick Ratio trinitybiotech.com
- financial results and valuation multiples details:
TRIB - Net Financial Result|Future Profit Trinity Biotech plc|TRIB - Market Price to Net Income Ratio|Projected Price to Earnings Trinity Biotech|TRIB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Trinity Biotech plc|TRIB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Trinity Biotech|TRIB - Earnings per share for the last twelve months|Quarterly EPS earnings growth trinitybiotech.com|TRIB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Trinity Biotech plc
Summary company analysis:Trinity Biotech Corp TRIB
This multiple compares the total enterprise value, including debt, with operating profit before taxes and depreciation, allowing for an assessment of the real value of assets relative to their ability to generate cash flow. By analyzing the change in the EV/EBITDA value over time, a conservative investor confirms the stability of Trinity Biotech plc (TRIB), whose operations in the global diagnostics sector under the protection of European law minimize risks during long-term capital planning.
Analysis of competing companies
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio QDEL (QuidelOrtho)|Enterprise Value to Operating Income Before Depreciation Ratio OPK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Business Value to Operating Income Before Depreciation MRVI|Fulgent Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Standard BioTools Corp LAB|Cytek Biosciences, Inc. (CTKB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OSUR|XGN (Exagen Inc) - EV/EBITDA Multiple|MDxHealth S.A. (MDXH) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio LUCD (Lucid Diagnostics Inc)|Enterprise Value to Operating Income Before Depreciation Ratio PRE|Insight Molecular Diagnostics Inc - Enterprise Value to EBITDA Ratio|prophaselabs.com (PRPH) - Company Value to EBITDA|AIMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CODX (Co-Diagnostics Inc)|HSCS: EV/EBITDA Multiple|BMRA (Biomerica Inc) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|onconetix.gcs-web.com (ONCO) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Virax Biolabs (VRAX)|BJDX - Company Value to EBITDA|Vermillion - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio AXDX (Accelerate Diagnostics Inc)|CENTOGENE, N.V. - EV/EBITDA Multiple|Company Value to EBITDA Enzo Biochem, Inc.|FRES: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Genetic Technologies Limited|ME (23andMe Inc.) - EV/EBITDA Multiple|PMD: Business Value to Operating Income Before Depreciation
